
Doyle Lowther, LLP is investigating potential breaches of fiduciary duty and other violations of state law by the Board of Directors of Cost Plus, Inc. (“Cost Plus”) (Nasdaq: CPWM) in connection with the sale of the Company to Bed Bath & … [Read More...]

The Medtronic InFuse Bone Graft was approved by the Food & Drug Administration (FDA) as a bone growth product to be utilized in anterior lumbar fusion surgeries. InFuse contains a protein which is designed to stimulate bone growth in patients who … [Read More...]

Traders or investors who purchased platinum or palladium from October 2007 through June 2008, including traders or investors who used MONEX to purchase platinum or palladium on the spot market, may have a claim against Moore Capital and its … [Read More...]